BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 460553)

  • 21. Physiopathological criteria of vasospasm treatment.
    Tommasino C; Picozzi P
    J Neurosurg Sci; 1998 Mar; 42(1 Suppl 1):23-6. PubMed ID: 9800598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications of hypervolemic therapy.
    Levy ML; Zelman V; Day J; Giannotta SL
    J Neurosurg; 1993 Nov; 79(5):798-800. PubMed ID: 8410266
    [No Abstract]   [Full Text] [Related]  

  • 23. Regional cerebral blood flow studies in subarachnoid hemorrhage.
    Heilbrun MP; Olesen J
    Eur Neurol; 1972; 8(1):1-7. PubMed ID: 5052144
    [No Abstract]   [Full Text] [Related]  

  • 24. Phase I trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
    Zabramski JM; Spetzler RF; Lee KS; Papadopoulos SM; Bovill E; Zimmerman RS; Bederson JB
    J Neurosurg; 1991 Aug; 75(2):189-96. PubMed ID: 1906534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Conservative principles in the therapy of subarachnoid hemorrhage].
    von Planta M; Ritz R
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1333-7. PubMed ID: 3527644
    [No Abstract]   [Full Text] [Related]  

  • 26. The relation between cerebral blood flow velocities as measured by TCD and the incidence of delayed ischemic deficits. A prospective study after subarachnoid hemorrhage.
    Jarus-Dziedzic K; Juniewicz H; Wroñski J; Zub WL; Kasper E; Gowacki M; Mierzwa J
    Neurol Res; 2002 Sep; 24(6):582-92. PubMed ID: 12238625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring of volume status after subarachnoid hemorrhage.
    Gress DR;
    Neurocrit Care; 2011 Sep; 15(2):270-4. PubMed ID: 21751101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ferrous iron chelator to treat subarachnoid haemorrhage.
    Fricker J
    Mol Med Today; 1997 Jun; 3(6):232. PubMed ID: 9211408
    [No Abstract]   [Full Text] [Related]  

  • 29. Modern management of aneurysmal subarachnoid hemorrhage.
    Shapiro S
    Indiana Med; 1991 Dec; 84(12):868-70. PubMed ID: 1774458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subarachnoid hemorrhage from ruptured intracranial aneurysms. Timing of pathophysiological events and surgery. A survey.
    Tomasello F; Picozzi P; Spadaro A; Albanese V
    Acta Neurol (Napoli); 1981 Jun; 3(3):517-31. PubMed ID: 7025587
    [No Abstract]   [Full Text] [Related]  

  • 31. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage.
    Findlay JM; Weir BK; Kassell NF; Disney LB; Grace MG
    J Neurosurg; 1991 Aug; 75(2):181-8. PubMed ID: 1906533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Must one be a global end-diastolic index master to treat subarachnoid hemorrhage?
    Mailloux P
    Crit Care Med; 2014 Jun; 42(6):1537-8. PubMed ID: 24836785
    [No Abstract]   [Full Text] [Related]  

  • 33. Crescendo transient Aura attacks: a transient ischemic attack mimic caused by focal subarachnoid hemorrhage.
    Izenberg A; Aviv RI; Demaerschalk BM; Dodick DW; Hopyan J; Black SE; Gladstone DJ
    Stroke; 2009 Dec; 40(12):3725-9. PubMed ID: 19893001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can global end-diastolic volume index influence the occurrence of delayed cerebral ischemia and pulmonary edema after subarachnoid hemorrhage?
    Mallat J
    Crit Care Med; 2014 Jul; 42(7):e544-5. PubMed ID: 24933076
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiac performance enhancement and hypervolemic therapy.
    Levy ML; Day JD; Zelman V; Giannotta SL
    Neurosurg Clin N Am; 1994 Oct; 5(4):725-39. PubMed ID: 7827481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study.
    Stolke D; Seifert V
    Neurosurgery; 1992 Jun; 30(6):877-81. PubMed ID: 1614590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dopamine beta-hydroxylase activity after subarachnoid hemorrhage].
    Markiewicz P
    Pol Tyg Lek; 1989 Jan; 44(5):109-11. PubMed ID: 2813161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of subarachnoid hemorrhage on cerebral blood volume, blood flow, and oxygen utilization in humans.
    Grubb RL; Raichle ME; Eichling JO; Gado MH
    J Neurosurg; 1977 Apr; 46(4):446-53. PubMed ID: 845630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [High dose nicardipine therapy for delayed cerebral vasospasm after aneurysmal subarachnoid hemorrhage].
    Kohno H; Kawano T; Tanaka N; Honma T; Okada T; Satoh K
    No Shinkei Geka; 1993 Nov; 21(11):999-1003. PubMed ID: 8255388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prophylactic treatment of vasospasm with nimodipine in subarachnoid hemorrhage].
    Procházka M; Gazdíková K; Cigánek L; Koprdová I
    Cas Lek Cesk; 1990 Feb; 129(8):237-9. PubMed ID: 2331740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.